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Profiling Enzyme Activities In Vivo
Using Click Chemistry Methods
methods suffer from a lack of resolving power [4–6],
which limits their ability to detect certain classes of pro-
teins, including membrane-associated and low-abun-
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The Scripps Research Institute dance proteins. More advanced strategies for proteome
analysis have subsequently been introduced, including10550 North Torrey Pines Road
La Jolla, California 92037 isotope-coded affinity tagging (ICAT) [7], which enables
the comparative analysis of protein expression levels by
liquid chromatography-tandem MS (LC-MS/MS). LC-based
strategies have overcome some of the resolution prob-Summary
lems of 2DE, providing improved access to membrane-
associated and low-abundance proteins [8]; however,Methods for profiling the activity of enzymes in vivo
these techniques, like 2DE, focus primarily on measuringare needed to understand the role that these proteins
variations in protein abundance and therefore provideand their endogenous regulators play in physiological
only an indirect estimate of changes in protein activity.and pathological processes. Recently, we introduced
In response to these limitations, activity-based proteina tag-free strategy for activity-based protein profil-
profiling (ABPP) has been introduced as a complementing (ABPP) that utilizes the copper(I)-catalyzed azide-
to abundance-based genomic and proteomic tech-alkyne cycloaddition reaction (“click chemistry”) to
niques [9, 10]. ABPP utilizes active site-directed chemi-analyze the functional state of enzymes in living cells
cal probes to determine the functional state of enzymesand organisms. Here, we report a detailed character-
in complex proteomes, distinguishing, for example, ac-ization of the reaction parameters that affect click
tive enzymes from their inactive precursors (e.g., zymo-chemistry-based ABPP and identify conditions that
gens) [11] and/or inhibitor-bound forms [11–13]. ABPPmaximize the speed, sensitivity, and bioorthogonality
probes consist of at least two elements: (1) a reactiveof this approach. Using these optimized conditions,
group (RG) for binding to and covalently labeling thewe compare the enzyme activity profiles of living and
active sites of many members of an enzyme class (orhomogenized breast cancer cells, resulting in the iden-
classes) and (2) one or more reporter tags (e.g., biotintification of several enzymes that are labeled by activ-
and/or a fluorophore) for the rapid detection and isola-ity-based probes in situ but not in vitro.
tion of probe-labeled enzymes (Figure 1A). A binding
group (BG) may also be used to promote probe inter-
Introduction actions with particular enzyme active sites. To date,
activity-based probes have been developed for over a
The continuing success of genome sequencing efforts dozen classes of enzymes, including serine hydrolases
has laid the foundation for understanding the molecular [11, 12], cysteine proteases [13–16], protein tyrosine
basis of life in its many forms. However, this task in- phosphatases [17], and glycosidases [18], as well as
volves not only the characterization of genes but the multiple oxidoreductases [19, 20] (for review see [21]).
products of gene expression as well. As primary media- However, in pursuit of the ultimate goal of characteriz-
tors of most physiological and pathological processes, ing the function of all proteins in parallel and in the most
proteins may be viewed as the next major challenge, physiologically relevant settings possible (i.e., in vivo),
especially considering the difficulties involved in devel- ABPP, like other proteomic approaches, is still in need
oping and applying methods for the global analysis of of improvement. For example, until recently, ABPP ex-
proteins (proteomics) as compared to DNA or RNA mole- periments were conducted almost exclusively with cell
cules (genomics) [1]. For example, unlike oligonucleo- and tissue homogenates rather than living cells and
tides, proteins exhibit a diverse array of chemical and organisms. Because physical disruption of cells/tissues
biochemical properties, are not amenable to molecular may alter the concentrations of endogenous protein
amplification, and do not possess predefined comple- activators/inhibitors, as well as their subcellular distribu-
mentary binding partners. Despite the many technical tions, in vitro proteomic preparations can only approxi-
challenges that accompany the analysis of proteins, the mate the functional state of proteins in a living cell or
need for global strategies to characterize the expression organism. A traditional limitation to applying ABPP
and function of these biomolecules is clear, especially probes in vivo has been the nature of their bulky reporter
given the multitude of posttranscriptional and posttrans- tags, which are typically quite large (700–1000 Da) and
lational processes that regulate the activity of proteins therefore limit probe uptake and distribution in cells and
in cells and tissues [2]. tissues. Thus, to accommodate in vivo profiling, a “tag-
Initial strategies for proteomics sought to collectively free” version of ABPP was introduced, whereby a re-
profile the expression levels of proteins using two- porter group could be attached to the activity-based
dimensional gel electrophoresis (2DE), staining, and probe following covalent labeling of enzyme targets [22]
mass spectrometry (MS) for protein separation, quanti- (Figure 1B). This conjugation step was accomplished
tation, and identification, respectively [3]. However, 2DE by engineering into the probe and tag a pair of small,
bioorthogonal coupling partners, the azide and alkyne,
which can react via Huisgen’s 1,3-dipolar cycloaddition*Correspondence: cravatt@scripps.edu
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Figure 1. Comparison of Standard and Click
Chemistry ABPP
ABPP probes consist of a reactive group
(RG), binding group (BG), and tag (e.g., rhoda-
mine and/or biotin). In contrast to standard
ABPP, click chemistry ABPP allows for the
profiling of living cells and organisms by
treating these specimens with tag-free azide-
or alkyne-modified probes, which are then
conjugated in vitro to the complementary al-
kyne- or azide-modified tag under cycloaddi-
tion reaction conditions to visualize probe-
labeled proteins.
to form a stable triazole product. This cycloaddition re- probe (PSN3, 1) and an alkyne-derivatized rhodamine
reporter tag (Rh, 4) (Figure 2) were used to profileaction is typically quite slow [23, 24], and it was not
until the Sharpless [25] and Meldal [26] labs reported a enzyme activities in complex proteomes. This tag-free
strategy for ABPP proved capable of profiling severalCu(I)-catalyzed stepwise analog of Huisgen’s concerted
triazole synthesis (“click chemistry” [23]) and Finn and enzyme activities both in vitro and in vivo; however, a
direct comparison of CC- and standard ABPP revealedcolleagues demonstrated its general biocompatibility
[27] that this reaction became potentially feasible for that the former method suffered from higher background
(i.e., heat-insensitive, nonspecific) labeling with pro-ABPP. (For review see [28].) Using the click chemistry
(CC) methodology, we were able to label several en- teomes, which reduced its sensitivity and hindered
the detection of specifically labeled low-abundancezymes with an azido-phenyl sulfonate ester activity-based
probe, both in vivo and in cell/tissue homogenates, effect targets of the PSN3 probe [22]. Here, we have systemati-
cally varied key reaction parameters of CC-ABPP toconjugation of an alkyne-tag via the cycloaddition reac-
tion, and separate/visualize the probe-labeled proteins determine the basis for the elevated background re-
by gel electrophoresis and fluorescence scanning [22]. activity. Interestingly, removal of the PSN3 probe did not
The general success of such a tag-free approach was markedly affect the intensity of background labeling
further validated by the recent report by Ovaa et al. observed in either cell or tissue proteomes (Figure 3A,
describing the in vivo profiling of the proteasome using lanes 1 and 7), indicating that these signals corre-
the Staudinger ligation for probe-tag conjugation [29]. sponded to an SDS-stable (probably covalent) associa-
However, one drawback to CC-ABPP was noted in our tion between proteins and the Rh reporter tag. Rh
previous report [22]––the methodology suffered from background reactivity required CuSO4 (Figure 3B, lane
higher background labeling as compared to conven- 4 versus 5) and further increased when the ligand and/
tional ABPP. These background signals, which ap- or reducing agent tris(carboxyethyl)phosphine (TCEP)
peared to derive from low-level nonspecific labeling of were also included in the reaction (Figure 3B, lanes 1–3).
abundant proteins in the proteome, obscured the detec- Although the chemical basis for protein labeling by Rh
tion of some low-abundance specific targets of azido remains unknown, an alkane analog of Rh did not
activity-based probes, thus limiting the sensitivity of CC- exhibit any reactivity with proteomes (data not shown),
ABPP. We now report the successful resolution of this indicating that the alkyne is responsible for protein mod-
problem, as well as an optimized cycloaddition reaction ification. Given these findings, we next tested whether
protocol for CC-ABPP, including methodologies for pro- switching the directionality of the cycloaddition reaction
tein labeling, isolation, and identification. Using these would circumvent the increased background labeling of
optimized conditions, we have conducted a compara- CC-ABPP.
tive analysis of the enzyme activity profiles of living and Two alkyne phenyl sulfonate ester probes (PS4, 2
homogenized human breast cancer cells, resulting in and PS9, 3) and a rhodamine-azide tag (RhN3, 5) were
the identification of several enzymes that were labeled synthesized (Figure 2), and proteome reactions with
by activity-based probes in situ but not in vitro. these reagents were compared to those with the PSN3/
Rh pair. The soluble fraction (cytosol) of homogenized
Results tissue (mouse heart) or cell (human MDA-MB-435 cancer
cell line) proteomes was incubated with probe (5 M)
for 1 hr, and then the complementary tag (50 M) wasTesting the Effects of Probes, Tags, and Reaction
Parameters on the Specific and Nonspecific added to reactions, followed by TCEP (1 mM), ligand
(100M, see Figure 1B for structure), and CuSO4 (1 mM).Reactivity of Click Chemistry-ABPP
In our initial report of click chemistry (CC)-ABPP, an After 1 hr, reactions were analyzed by 1D-SDS-PAGE
and in-gel fluorescence scanning. As shown in Figureazide-modified phenyl sulfonate ester activity-based
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Figure 2. Chemical Structures of Azide and Alkyne Probes and Tags
Note: TriN3, 7 was synthesized on solid phase and thus has an amide group in the X position where it was attached to the resin.
3A, endogenously expressed enzyme activities (e.g., and 8); however, the strongest fluorescent signals were
achieved when ligand was also added to the reactionsenoyl-CoA hydratase 1 [ECH-1] and glutathione-S-trans-
ferase omega [GST]) were detected in cell/tissue pro- (lanes 1 and 6). Curiously, although protein labeling was
augmented in reactions with copper and ligand com-teomes using either version of CC-ABPP. Strikingly,
however, a significant reduction in background labeling pared to reactions containing only copper (e.g., lane 2
versus 4), the detection of specifically labeled enzymewas observed in the PS9/RhN3 CC reactions, which
could largely be attributed to the inertness of the RhN3 activities appeared particularly dependent on the pres-
ence of reducing agent (e.g., compare labeling intensityreporter tag, which showed negligible proteome labeling
in the absence of PS9 (Figure 3A, lanes 6 and 12). of ECH-1 in lane 1 versus 2 or lane 6 versus 7). Regard-
less, in all reactions examined, the PS9/RhN3 cycload-The reduced background labeling of the PS9/RhN3
reactions resulted in much improved signal to noise, dition pair was found to exhibit significantly reduced
background signals compared to PSN3/Rh.enabling the visualization of lower-abundance enzyme
activities, such as the heart aldehyde dehydrogenase-1 Finally, a comparison of the dependence of PS9/
RhN3 and PSN3/Rh reactions on tag concentration and(ALDH-1; Figure 3A, lane 4), which was more difficult to
detect in PSN3/Rh reactions due to nonspecific label- time (Figures 3C and 3D, respectively) revealed that both
cycloadditions proceeded to apparent completion bying of comigrating proteins (Figure 3A, lane 3).
A similar dependence on cycloaddition reaction com- 1 hr using 50 M tag, with the latter reaction showing
approximately 4-fold faster kinetics (Figure 3D; shownponents was observed for both the PS9/RhN3 and
PSN3/Rhproteome reactions (Figure 3B). For reactions for the PS target GST labeled in MDA-MB-435 pro-
teomes). Collectively, these data indicate that, while CCof either directionality, CuSO4 was necessary (lanes 5
and 10) but not sufficient (lanes 4 and 9) to promote in proteomes is likely not a simple process, it does ad-
here to general rules that enable the optimization of thisthe azide-alkyne cycloaddition. Significant signals were
observed when only CuSO4 and TCEP were used (lanes 3 strategy for functional proteomic investigations.
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Figure 3. Comparison of In Vitro Labeling of Enzymes in Complex Proteomes Using PSN3/Rh and PS9/RhN3 CC Pairs
(A) Three target enzymes, ALDH-1, ECH-1, and GST, are labeled by both CC pairs; Rh gives rise to significant background in the presence
and absence of PSN3. , heat-denatured proteomes. (B) Dependence of protein labeling on click chemistry reaction components. Strongest
fluorescent signals are observed when CuSO4, ligand, and TCEP are used in the cycloaddition reaction. (C and D) Fluorescence intensity of
GST labeling (in homogenates of MDA-MB-435 cells) as a function of (C) tag concentration and (D) cycloaddition reaction time. A tag
concentration of 50 M is sufficient to achieve maximum fluorescent intensity in 1 hr (C). The PSN3/Rh CC pair reacts to completion
approximately four times faster than the PS9/RhN3 CC pair (D; 50 M tag). Note: for (A) and (B) (and subsequent figures), fluorescent gel
images are shown in gray scale.
Once having established optimal conditions where the intensity of GST to signals of a serial dilution of purified
fatty acid amide hydrolase labeled to completion withCC reaction proceeded to completion in whole pro-
teomes, we then carried out a quantitative analysis of the a rhodamine-tagged fluorophosphonate probe [37] re-
sulted in an estimation of 0.1 pmol of GST per gelsensitivity limits of CC-ABPP. To estimate the minimal
amount of active enzyme detectable by CC-ABPP, it lane, or approximately 0.01% of the total soluble T-47D
proteome (26 g of protein loaded per lane). Notably,was first important to select an enzyme that reacted to
completion with PS probes. Indeed, although the relative however, the actual sensitivity limit of CC-ABPP was at
least 10-fold greater than this measurement, as GSTlevels of a given enzyme activity can be measured
across proteomes by ABPP under conditions of partial could still be detected when labeled to only 10% com-
pletion. Collectively, these data highlight that CC-ABPPprobe labeling [34], estimations of the absolute quantity
of active enzyme in a given proteome can only be made can quantitate the levels of active enzymes in whole
proteomes with high sensitivity.for fully probe-labeled enzymes [37]. Analysis of the
time- and probe concentration-dependence of PSN3/
T-47D proteome reactions determined that a 1 hr treat- Profiling Enzyme Activities In Vivo by CC-ABPP
Previously, we reported the utilization of the PSN3/Rhment with 10 M PSN3 was sufficient to completely
label the GST enzyme (Supplemental Figure S1 at CC pair for profiling enzyme activities in living cells and
organisms [22]. These studies capitalized on the remark-http: / /www.chembiol.com /cgi/content/ full/ 11/4/535/
DC1). Under these conditions, comparison of the signal able cellular stability of the azide group, which has also
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Figure 4. In Vivo Labeling of ALDH-1 in Mouse Liver
(A) Comparison of CC pairs. Clear fluorescent signals are observed for ALDH-1 when mice are treated (10, 20 mg/kg i.p.) with PS9 but not
PSN3. In vitro-labeled ALDH-1 shown for comparison (lanes 2 and 9) along with the associated heat controls (, lanes 1 and 10).
(B) In vitro chemical inhibition of ALDH-1 by disulfiram (0–100 M added 1 hr prior to reaction with 5 M PS9).
(C) In vivo chemical inhibition of ALDH-1 by disulfiram results in a 2.6-fold reduction in labeling intensity. Representative gel image shown
above the bar graph (n  3 per group).
been exploited for incorporation of this moiety into car- [35] directly in cell/tissue homogenates. Conceivably,
CC-ABPP could enable the extension of such inhibitorbohydrate and protein molecules in situ [30–33]. In con-
trast, fewer studies have explored the cellular stability profiling methods to evaluate the sites of action of
enzyme inhibitors in vivo. To test this notion, a pre-of aliphatic alkynes [33], making it less clear whether
CC-ABPP of the opposite directionality (alkyne probe/ liminary in vitro experiment was carried out with disul-
firam, a known active site-directed inhibitor of ALDH-1azide tag) would be applicable in vivo. To compare the
ability of the PS9 and PSN3 probes to detect enzyme [36]. Treatment of soluble liver homogenate with disul-
firam (50–100 M, 1 hr) completely blocked labeling ofactivities in vivo, these reagents were administered to
mice at doses of 10 or 20 mg/kg (intraperitoneal [i.p.]). ALDH-1 by PS9 (Figure 4B), confirming that CC-ABPP
could detect the chemical inhibition of enzymes in wholeAfter 1 hr, the animals were sacrificed, their liver tissue
removed and homogenized, and the soluble proteome proteomes. Next, mice were administered disulfiram
(100 mg/kg i.p.) or vehicle control 1 hr prior to treatmentfraction subject to CC reaction conditions. In-gel fluo-
rescence analysis of the reaction products revealed a with PS9 (10 mg/kg i.p.). After 1 hr, animals were sacri-
ficed and their liver tissue processed and analyzed bydramatic difference in the labeling profiles of the PS9
and PSN3 probes. While the primary PS-target in liver, CC-ABPP as described above. Disulfiram-treated mice
showed a 2.6-fold reduction in ALDH-1 labeling intensityALDH-1, was easily visualized with PS9 (Figure 4A,
lanes 6 and 7), the detection of this enzyme using the compared to vehicle-treated animals (Figure 4C). These
data indicate that CC-ABPP methods can read outPSN3 probe was obscured, at least in part, by strong
background labeling (Figure 4A, lanes 4 and 5). Consis- changes in enzyme activity in vivo due to the actions of
chemical inhibitors.tent with the in vitro studies described above, back-
ground signals in the PSN3/Rh in vivo experiments
were apparently due to direct proteome labeling by the Applications of CC-ABPP––The Identification
of Enzyme Activities Expressed in Living CellsRh tag (i.e., not dependent on the presence of the
PSN3 probe; compare lane 3 to lanes 4 and 5). Finally, One of the primary goals of ABPP is to identify enzyme
activities that are differentially expressed in human dis-it is worth noting that, even after accounting for differ-
ences in background labeling, the PS9 probe still la- ease. With this objective in mind, we recently applied
ABPP to discover several novel enzyme activities upreg-beled ALDH-1 with greater efficiency than the PSN3
probe in vivo, which contrasts with the nearly equivalent ulated in invasive human cancer cells [20, 37, 38]. In
these initial studies, however, enzymes were profiled inlabeling of ALDH-1 by these probes in vitro. Although
several factors may have accounted for the enhanced cancer cell extracts and, therefore, certain proteins that
were active only in the context of the living cell maylabeling of ALDH-1 by PS9 in vivo (e.g., superior distri-
bution and/or uptake of this probe compared to PSN3), have eluded detection. To explore this possibility, we
compared the enzyme activity profiles of two humanthese data, at a minimum, highlight that alkyne-modified
probes display suitable stability for profiling enzyme ac- breast cancer lines using both in vitro and in situ CC-
ABPP. One noninvasive, estrogen receptor (ER)-positivetivities in living animals.
line, T-47D, and one invasive, ER-negative line, MDA-
MB-231, were selected for analysis with the followingApplications of CC-ABPP––The Identification
of Targets of Enzyme Inhibitors In Vivo two goals: (1) to identify enzymes activities that were
differentially expressed in situ and in vitro and (2) toABPP has been applied to identify the enzyme targets of
several synthetic inhibitors [13, 34] and natural products identify enzyme activities that were differentially ex-
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Figure 5. Time and Concentration Dependence of In Situ Probe Labeling of T-47D Cancer Cells
In situ protein labeling as a function of probe incubation time ([A] and [B], 15 min to 4 hr, 25 M probe) and concentration ([C] and [D], 5–100
M probe, 1 hr). Graphical representation of protein labeling intensities (each normalized to percent of maximum intensity) for time and
concentration dependence gels shown in (B) and (D), respectively. For graph of absolute labeling intensities, see Supplemental Figure S2 on
Chemistry & Biology’s website.
pressed in noninvasive (T-47D) and invasive (MDA-MB- In situ profiles were then compared to profiles gener-
ated by in vitro ABPP to identify conditions where back-231) breast cancer cells.
Conditions were established for the analysis of in situ ground signals were normalized for both methods
(in situ labeling for 1 hr with 25 M probe in 5 ml cultureenzyme activity by treating living cancer cells for vari-
able incubation times (15 min–4 hr) with a range of media; in vitro labeling for 1 hr with 5 M probe and
2 mg/ml soluble proteome). Background signals wereconcentrations of two PS probes, PSN3 and PS4 (5–
100 M). Cells were then harvested and processed and defined as proteins that showed heat-insensitive label-
ing in vitro and typically corresponded to low-levelthe soluble proteome subject to CC reaction conditions.
As is shown in Figure 5A, clear time-dependent labeling modification of abundant proteins (as judged by com-
parison of probe labeling profiles to Coomassie blue-was observed for nearly all enzyme activities, confirming
that these proteins were modified by probes in situ stained gels; data not shown). Under normalized condi-
tions, the enzyme activity profiles of living cancer cells(rather than being, for example, artifactually labeled
posthomogenization). A wide range of labeling kinetics were quantitatively compared to those generated in vitro
(Figure 6). Several differentially expressed enzyme activ-was observed, with some enzyme activities reacting
to completion with PS probes within 1–2 hr (e.g., GST, ities could be detected by direct analysis of proteomes
by 1D-SDS-PAGE (Figure 6A); however, more completeECH-2) and other proteins exhibiting linear rates of label-
ing throughout the 4 hr time course (e.g., protein disul- enzyme activity profiles were generated by separation
of proteomes on a Q Sepharose anion exchange columnfide isomerase [PDI]) (Figure 5B). The rate of labeling of
this latter group of proteins could be increased by treat- prior to 1D-SDS-PAGE analysis (Figure 7A). Two general
types of enzyme activities were detected: (1) enzymesing cells with higher concentrations of probe (Figures
5C and 5D). Overall, the labeling profiles for the PSN3 that labeled equally well in situ and in vitro (e.g., GST)
and (2) enzymes that labeled more strongly in situ thanand PS4 probes were similar, with one notable excep-
tion: the enzyme very long chain acyl-CoA dehydroge- in vitro (e.g., VLCAD, PDI, ECH-2) (Figures 6B). Notably,
one enzyme activity, VLCAD, was labeled by the PSN3nase (VLCAD), which was detected exclusively with the
PSN3 probe. Enzymes were identified utilizing trifunc- probe exclusively in living breast cancer cells, sug-
gesting that homogenization resulted in the inactivationtional probes containing biotin and rhodamine groups
(Figure 2, compounds 6 and 7) and avidin chromatogra- of this protein.
As described previously [20, 22], the PS target GSTphy-mass spectrometry (MS) methods, as described in
the Experimental Procedures. was found to be highly upregulated in MDA-MB-231
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Figure 6. Comparison of In Situ and In Vitro Enzyme Activity Profiles of T-47D and MDA-MB-231 Cancer Cell Lines
(A) While some enzyme activities are labeled with equal intensity in situ and in vitro (e.g., GST), other enzyme activities show significantly
more probe labeling in situ compared to in vitro (e.g., VLCAD). Notable differences in protein activity between the invasive (MDA-MB-231)
and noninvasive (T-47D) cell lines were also observed (e.g., ECH-2). , heat-denatured proteomes.
(B and C) Levels of representative enzyme activities compared (B) in situ versus in vitro (shown for PSN3/Rh) and (C) in situ-labeled T-47D
versus MDA-MB-231 cells (n  3 per group).
cells as compared to T-47D cells (Figure 6C). In contrast, late protein function in living cells and tissues. For exam-
ple, the activities of enzymes are often controlled byin situ labeling identified an enoyl-CoA hydratase (ECH)
that showed higher activity in T-47D cells than MDA-MB- protein-protein interactions [2], which are sensitive to
the endogenous concentrations and/or subcellular lo-231 cells (Figure 6C). Interestingly, database searches
revealed that this enzyme represents a previously un- calizations of regulatory proteins. Recently, we intro-
duced a tag-free strategy for activity-based protein pro-characterized ECH that shows 97% sequence identity
with human ECH-1 [39]. Multiple tryptic peptides were filing (ABPP) in vivo, which enables the detection of
enzyme activities in their native cellular environmentobtained for the PS-labeled breast cancer ECH that dis-
tinguished it from ECH-1 (Figure 7B). Accordingly, we [22]. This tag-free version of ABPP was accomplished
by engineering into activity-based probes and reporterhave named this novel human ECH variant ECH-2. Col-
lectively, these results highlight that in situ profiling by tags an azide and alkyne group, respectively, which can
react to form a stable triazole product via the Huisgen’sCC-ABPP facilitates the identification of (1) enzymes
that are labeled by activity-based probes predominantly 1,3-dipolar cycloaddition reaction (click chemistry [23]).
Here, we have conducted a thorough characterizationor exclusively in living cells, (2) enzymes that are
differentially expressed in invasive (MDA-MB-231) and of click chemistry (CC)-ABPP and, by addressing several
technical shortcomings and challenges, identified opti-noninvasive (T-47D) breast cancer cells, and (3) novel
enzyme activities. mal conditions for profiling enzyme activities in living
cells and organisms by this method.
The first experimental challenge addressed in thisDiscussion
study was the inferior sensitivity of CC-ABPP compared
to standard ABPP. In our original description of CC-ABPP,Proteomic experiments are typically performed with
proteomes were treated with an azide-modified phenylcell/tissue samples prepared in vitro. Accordingly, these
studies may fail to account for dynamic events that regu- sulfonate ester probe (PSN3) and protein-labeling events
Chemistry & Biology
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Figure 7. Q-Sepharose Chromatography of In Situ and In Vitro Probe-Labeled T-47D Proteomes Enhances the Visualization of Differentially
Expressed Enzyme Activities
(A) Several proteins that exhibited stronger or exclusive labeling in situ are boxed, including enzyme activities that could be detected by 1D-
SDS-PAGE analysis of whole proteomes (e.g., ECH-2, PDI, VLCAD; see Figure 6A) and other proteins that were more effectively visualized
following Q fractionation (asterisks).
(B) MS peptide data (black text) for a novel human enoyl-CoA hydratase variant, ECH-2. Residues that distinguish ECH-2 from the previously
identified ECH-1 [39] are boxed.
were visualized upon reaction with an alkyne-derivatized of CC-ABPP revealed that PSN3/Rh reactions were
faster, reaching completion in approximately one-fourthrhodamine tag (Rh) [22]. Although this version of CC-
ABPP detected enzyme activities in whole proteomes the time of PS/RhN3 reactions. Thus, each version of
CC-ABPP possesses distinct advantages: the PSN3/with signal intensities comparable to standard ABPP
methods, it also suffered from significantly higher back- Rh pair may be more applicable when rapid sample
analysis is desired, while the PS/RhN3 combinationground labeling both in vitro and in vivo. Here, we deter-
mined that the background labeling of PSN3/Rh reac- should be more suitable for investigations requiring the
highest level of sensitivity.tions was not dependent on the presence of the azide
probe and thus could be attributed to the reactivity of Having observed superior sensitivity with the PS/
RhN3 pair, we next asked whether this version ofthe alkyne reporter tag. This nonspecific modification
of proteins by Rh was only observed in the presence CC-ABPP could be applied in vivo. Indeed, while azides
are known to exhibit exceptional cellular stability andof copper and was further exacerbated by ligand and
TCEP. In contrast, no background proteome labeling have been exploited by several groups for the in situ
modification of biomolecules [30–33], less is understoodwas detected with an azide-modified Rh tag (RhN3)
either in vitro or in vivo. As a consequence, CC-ABPP about the suitability of alkynes as components of cellular
probes. For example, alkynes could be prone to enzy-reactions conducted with a PS probe and RhN3 tag
showed significantly improved signal to noise and sensi- matic reduction in vivo, especially in metabolically active
tissues like the liver [40]. However, we found that alkyne-tivity, facilitating the visualization of low-abundance en-
zyme activities that eluded detection in PSN3/Rh reac- modified phenyl sulfonate ester probes served as excel-
lent profiling agents both in living cells and organisms,tions. Still, a comparison of the kinetics of each version
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permitting, for example, the in vivo detection of the liver from nonspecific protein labeling events is more chal-
lenging for in vivo ABPP studies, which lack the straight-enzyme activity aldehyde dehydrogenase-1 with a signal
intensity and sensitivity that surpassed that of the PSN3 forward controls devised for in vitro ABPP (e.g., compar-
ative profiling of native and heat-denatured proteomes).probe. Thus, these findings suggest that either azide-
or alkyne-modified activity-based probes can be utilized Accordingly, confirmation that probe-enzyme reactions
observed in vivo actually occur in enzyme active sitesto profile enzyme activities in vivo.
To date, standard ABPP methods have been applied (i.e., in an “activity-based” manner) may require the iden-
tification of sites of probe modification. Fortunately, ato several biological systems, enabling the discovery of
both disease-associated enzyme activities and specific gel-free version of ABPP has recently been introduced
to identify specific sites of probe labeling on enzymesinhibitors of these enzymes using cell/tissue homo-
genates [21]. Here, we have demonstrated that similar isolated from whole proteomes [46]. Thus, a combina-
tion of gel-based and gel-free methods for CC-ABPPbiological applications can be pursued in vivo using
CC-ABPP. For example, the inhibition of ALDH-1 in vivo should enable both the identification and thorough char-
acterization of probe-enzyme reactions that occur inby the active site-directed agent disulfiram could be
quantified by CC-ABPP, indicating that this method may vivo. When applying ABPP in vivo, one must also con-
front the problem of interpreting the biological signifi-be used to confirm whether and to what extent drugs
inhibit their intended (as well as potentially unintended) cance of probe-enzyme reactions that occur in living
cells/organisms but not in vitro. Although the most obvi-targets in animal models. Given the myriad issues that
may affect the efficacy of inhibitors in animals, including ous (and perhaps enticing) interpretation of such data
is that they reflect enzyme activities that are tightlyuptake, distribution, and metabolism, the value of new
technologies that can assess inhibitor activity in vivo is regulated by posttranslational mechanisms (e.g., CoA
persulfide inactivation of VLCAD), other explanationsevident. In this regard, however, it should be noted that
disulfiram is a covalent inhibitor of ALDH-1 and therefore are also possible. For example, if certain activity-based
probes distribute into specific cellular compartmentssimpler to evaluate by ABPP than reversible inhibitors,
for which more complex kinetic factors must be taken (rather than equally throughout the cell), then enzyme
activities localized to these structures may show dis-into account. Still, standard ABPP has recently been
adapted for the analysis of reversible enzyme inhibitors proportionately enhanced labeling in vivo. In the end,
sorting through the intriguing biological implications af-in cell/tissue homogenates [34], and, following a similar
approach, we anticipate that CC-ABPP can be optimized forded by in vivo activity-based profiling will likely re-
quire detailed biochemical and cell biological investiga-for the characterization of the activity of reversible inhibi-
tors in vivo. tions. Regardless, it is clear from the studies described
herein that CC-ABPP offers a valuable complement toWe also applied CC-ABPP to compare the in situ ver-
sus in vitro enzyme activity profiles of human breast standard ABPP methods, especially for the identifica-
tion and characterization of enzymes that are regulatedcancer cell lines, resulting in the identification of en-
zymes that were labeled by PS probes predominantly by posttranslational mechanisms in vivo.
or exclusively in living cells but not in cell homogenates.
These enzymes included a novel enoyl-CoA hydratase Significance
variant ECH-2 that was upregulated in noninvasive
breast cancer cells; PDI, a multifunction enzyme that The field of proteomics aims to develop and apply
methods for the global analysis of protein expressioncatalyzes the formation and isomerization of disulfide
bonds in addition to functioning as a molecular chaper- and function. Toward this end, strategies for profiling
protein activity in vivo would be particularly valuable.one and subunit of prolyl 4-hydroxylase and microsomal
triglyceride transfer protein [41–43]; and VLCAD, a mito- Here, we describe the detailed characterization of a
tag-free version of activity-based protein profiling (ABPP)chondrial flavoprotein that catalyzes the  oxidation of
very long chain acyl-CoA esters [44, 45]. Interestingly, that utilizes the azide-alkyne cycloaddition reaction
(click chemistry) to analyze the functional state ofprevious studies have shown that VLCAD, as well as
other acyl-CoA dehydrogenases, are rapidly inactivated enzymes in living cells and animals. We establish
conditions that maximize the speed, sensitivity, andby binding to CoA persulfide in cell and/or tissue prepa-
rations [45]. This event, also referred to as “greening” bioorthogonality of click chemistry-ABPP and apply
this strategy to identify enzymes that are labeled bybecause it results in dehydrogenases appearing green
in color, has been suggested to reflect a mode by which activity-based probes in vivo but not in vitro. Notably,
some of these enzyme activities were differentiallythese enzymes may be regulated posttranslationally
in vivo [45]. Thus, the selective labeling of VLCAD in expressed in invasive and noninvasive breast cancer
cells, suggesting that they may represent novel mark-living breast cancer cells may reflect the inactivation of
this enzyme by CoA persulfide upon homogenization. ers and/or targets for this disease. Additionally, click
chemistry-ABPP was used to measure changes in en-More generally, these findings highlight the value of per-
forming ABPP experiments in living cells, especially for zyme activity in mice due to the action of chemical
inhibitors, indicating that this method may be imple-enzyme activities that are sensitive to posttranslational
forms of regulation. mented to test whether drugs inhibit their intended
targets in vivo. Collectively, these studies highlight theSeveral challenges still face the application of
CC-ABPP and related methods for profiling enzyme value of click chemistry-ABPP and related functional
proteomic methods that can evaluate the activity offunction in vivo, especially as pertains to data analysis
and interpretation. For example, distinguishing specific proteins in living cells and organisms.
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Experimental Procedures channel multipipettors to facilitate higher throughput. For time
course experiments with GST, reactions were quenched with load-
Synthesis of Probes and Tags ing buffer containing either 10 mM 5-hexyn-1-ol (for PSN3/Rh) or
See Supplemental Data on Chemistry & Biology’s website. 10 mM 6-azido hexan-1-ol (for PS9/RhN3) to block any further
cycloaddition between probe-labeled enzymes and the azide/alkyne
tags. Proteins were separated by 1D SDS-PAGE (26 g of protein/Proteome Sample Preparation, Probe Labeling,
gel lane) and visualized in-gel using a Hitachi FMBio IIe flatbedCycloaddition, and Protein Detection
laser-induced fluorescence scanner (MiraiBio, Alameda, CA). La-Preparation of Mouse Tissue Soluble Proteomes
beled proteins were quantified by measuring integrated band inten-Mouse tissues were Dounce homogenized in 10 mM sodium/potas-
sities (normalized for volume). For all quantification experiments,sium phosphate buffer (pH 8.0) (PB), and the soluble fraction was
n  3 trials per data point and error represents standard deviationisolated using high-speed centrifugation to remove the heavy and
of the average of these values.light membrane components: 22,000  g (30 min, pellet  heavy
membrane fraction) and 100,000  g (60 min, pellet  light mem-
brane, supernatant  soluble fraction). Prepared soluble proteome
Protein Isolation and Identification from Cancer Cell Linessamples were diluted to 2.0 mg/ml in PB and stored at 80	C
In standard ABPP, biotinylated and/or trifunctional probes (bearinguntil use.
both biotin and rhodamine functional groups) are utilized to affinityPreparation of Cell Line Soluble Proteomes
Cell lines were grown to 80% confluency in RPMI-1640 medium purify enzyme activities, enabling their identification by mass spec-
(Invitrogen) containing 10% fetal calf serum (FCS). Cells were har- trometry techniques [38]. Similarly, for CC-ABPP, trifunctional
vested, sonicated, Dounce homogenized in PB, and centrifuged at azides or alkynes were employed as reporter tags. Large-scale cell
100,000  g (45 min) to isolate the soluble fraction (supernatant). cultures (3 to 4  150 mm plates, each containing 10 ml medium)
Prepared samples were diluted to 2.0 mg/ml in PB and stored were treated with PS probe for 2 to 4 hr (depending on labeling
at 80	C until use. kinetics of target protein), after which point cells were washed,
In Vitro Labeling of Proteins homogenized, and centrifuged to isolate the soluble fraction as
Proteome samples (43 l of 2.0 mg/ml protein in PB) were treated described above. The soluble proteome (2.5 ml at 2 to 3 mg/ml) was
with 5 M (unless otherwise indicated) PS probe (44 stock in applied to a PD-10 size exclusion column and eluted with 3.5 ml
dimethyl sulfoxide [DMSO]) for 1 hr at room temperature (43 l PB. Proteomic samples were then fractionated by Q-Sepharose
reactions were set up so that, once the cycloaddition reagents were chromatography (0–2 M NaCl gradient). Diagnostic cycloaddition
added, the total reaction volume would be 50 l). For heated con- reactions (20 l of each 500 l fraction) were then run to identify
trols, proteome samples were heated at 80	C for 5 min prior to fractions containing desired protein(s), which were then reacted
addition of PS probe. To facilitate higher throughput, probe reac- with the appropriate trifunctional probe (20 M; 180 l reactions).
tions (and cycloadditions) were carried out in PCR tubes (strips of After 1 hr, cold PB (200 l) was added, and the reactions were
12 200l) using multichannel multipipettors to dispense reagents. centrifuged (5900 g, 4 min, 4	C) to pellet the protein. The superna-
In Vivo Labeling of ALDH-1 in Mice tant containing excess cycloaddition reagents was removed, and
Mice were given intraperitoneal (i.p.) injections of 10 or 20 mg/kg cold methanol (200 l) was added to the protein pellet, which was
PS probe (in vehicle [18:1:1 saline:emulphor:EtOH]). (Mock injected resuspended by sonication (3–5 s) and allowed to rotate at 4	C for
mice received i.p. injection of vehicle alone.) After 1 hr, the mice 10 min. The sample was then centrifuged (5900  g, 4 min, 4	C)
were anesthetized in O2/CO2 mixture, sacrificed by decapitation, and the supernatant removed. Following a second methanol wash,
and liver tissue was collected, frozen in dry ice (30 min), and pro-
proteins were solubilized in PB containing 0.5% SDS via sonication
cessed as described to isolate the soluble proteome. For inhibition
(3–5 s) and affinity-isolated using avidin-agarose beads (Sigma) as
experiment with disulfiram, mice were given i.p. injections of 100
described previously [11, 19]. Affinity-isolated proteins were sepa-
mg/kg disulfuram (in vehicle [18:1:1 saline:emulphor:DMSO]) 1 hr
rated/visualized by SDS-PAGE and in-gel fluorescence scanning.prior to administration of PS9 (10 mg/kg, 1 hr) and treated as
Previously, Coomassie staining was used to directly visualize thedescribed above to isolate soluble liver proteome. (Mice used for
protein band, which was then removed for mass spectrometry (MS)nondisulfiram comparison received injection of vehicle alone.)
analysis. However, even after enrichment, probe-labeled proteinsIn Situ Labeling of Proteins in Cancer Cell Lines
were often difficult to see by Coomassie staining, and distortion ofCell lines were grown to 80% confluency in RPMI-1640 medium
the gel during the stain/destain process made comparison with(Invitrogen) containing 10% FCS. Prior to in situ labeling, cell cultures
the fluorescent image/Western blot difficult. We found that it waswere washed (2 5 ml Dulbecco’s phosphate buffered saline [PBS],
effective to cut the protein bands out of the unstained gel using aInvitrogen) and fresh medium (5 ml RPMI-1640 containing 10% FCS)
corresponding fluorescent gel image as a template. After the initialwas added. Cell cultures were treated with 25 M (unless otherwise
fluorescent scan, sections above and below the band of interestindicated) PS probe (1000 stock in DMSO) for 1 hr (unless other-
were carefully excised, the gel rescanned, and the cut refined. Afterwise indicated), then washed (2  5 ml Dulbecco’s PBS) and pro-
two to three iterations, the band was sufficiently localized that itcessed as described to isolate soluble proteome.
could be cleanly removed. In addition to shortening the protein
isolation protocol, the stain-free procedure increased certainty ofCycloaddition Reactions, Protein Electrophoresis,
cutting the right band and it alleviated the need to use stainingand In-Gel Fluorescence Scanning
reagents that could complicate protein identification. Isolated gelFollowing incubation with the PS probe (see above), 50–100 M of
slices were washed with methanol:water:acetic acid (5:4:1) for 1 hr,the appropriate tag (50 stock in DMSO) was added to each protein
then methanol:water (1:1; 1 hr, then 12 hr with fresh solution) andsample (44 l in PB), followed by 1 mM TCEP (50 stock in water)
subject to in-gel trypsin digest. The resulting peptides were analyzedand 100 M ligand (17 stock in DMSO:t-butanol 1:4), giving a
by nanoLC-MS/MS and results searched against public databasest-butanol concentration of 5%. Samples were gently vortexed and
to identify probe-labeled proteins. VLCAD (gi:18044943) was inde-1 mM CuSO4 (50 stock in water) was added to each proteome
pendently identified from both T-47D and MDA-MB-231 cells, andsample, making the total reaction volume 50 l. Samples were vor-
ECH-2 (gi:15080016) and PDI (gi: 20070125) were identified fromtexed again and allowed to react at room temperature for 1 hr (unless
T-47D cells.otherwise indicated), at which time 50 l (1 volume) of standard
2SDS-PAGE loading buffer (reducing) was added to each reaction.
Note that this optimized protocol differs from that previously re-
Supplemental Dataported in several aspects: the reactions were not run under an
The Supplemental Data available at http://www.chembiol.com/cgi/inert atmosphere, no effort was made to exclude DMSO, a lower
content/full/11/4/535/DC1 includes synthesis of probes and tagsconcentration of ligand was used (100 M versus 2 mM), and excess
and graphs of in vitro (GST) and in situ enzyme labeling in T-47Dreagents were not removed prior to electrophoresis. As mentioned
above, reactions were also carried out in PCR tubes using multi- proteome.
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